Comparison of efficacy and safety of twice-daily Glycopyrronium/Formoterol combination with once-daily Glycopyrronium in patients with moderate to severe COPD

被引：1

作者：

Salvi, Sundeep ^{[1
]}

Kumar, Anand ^{[2
]}

Agrawal, Sumit ^{[3
]}

Leuva, Amrutlal ^{[4
]}

Shukla, Vineet ^{[5
]}

Deshpande, Shrikant ^{[6
]}

Balamurugan, Santhalingum ^{[7
]}

Singh, Ajeet ^{[8
]}

Tikkiwal, Sharad ^{[9
]}

Gupta, Sandeep ^{[10
]}

Sawant, Sandesh ^{[11
]}

Vaidya, Abhijit ^{[11
]}

Gogtay, Jaideep ^{[11
]}

机构：

[1] Chest Res Fdn, Pune, Maharashtra, India

[2] GSVM Med Coll, Kanpur, Uttar Pradesh, India

[3] Oyster & Pearl Hosp, Pune, Maharashtra, India

[4] Shree Sayaji Gen Hosp & Govt Med Coll, Vadodara, India

[5] KRM Hosp & Res Ctr, Lucknow, Uttar Pradesh, India

[6] Dr Deshpandes Ashirwad Hosp, Ulhasnagar, Maharashtra, India

[7] Sri Muthukumaran Med Coll Hosp & Res Inst, Chennai, Tamil Nadu, India

[8] SMS Hosp & Med Coll, Jaipur, Rajasthan, India

[9] Asthma Bhawan, Jaipur, Rajasthan, India

[10] MV Hosp & Res Ctr, Lucknow, Uttar Pradesh, India

[11] Cipla Ltd, Mumbai, Maharashtra, India

来源：

关键词：

COPD; -; management; Treatments; Bronchodilators;

D O I：

10.1183/13993003.congress-2019.PA2476

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

PA2476

引用

页数：2